Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-276615

BELITE BIO, INC · BLTE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Hendrik Peter Scholl
Officer — Chief Medical Officer
Period of report
Jun 18, 2026
Accepted (ET)
Jun 22, 2026 · 6:05 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001889109

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
American depositary shareF1Jun 18, 2026S96$143.90D24,904IBy Bioptima Ltd.
American depositary shareF1,F2Jun 18, 2026S3,748$144.6617D21,156IBy Bioptima Ltd.
American depositary shareF1,F3Jun 18, 2026S4,861$145.4348D16,295IBy Bioptima Ltd.
American depositary shareF1,F4Jun 18, 2026S1,199$146.2449D15,096IBy Bioptima Ltd.
American depositary shareF1Jun 18, 2026S96$147.11D15,000IBy Bioptima Ltd.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses